UTI INC. Acquires and Cancels KRW 6.95B Convertible Bonds Due to Put Option Exercise, Short-term Liquidity Pressure Persists
UTI INC. announced the acquisition of KRW 6.95B (including principal and accrued interest) of its 1st series private convertible bonds issued in May 2024 through over-the-counter purchase, following the exercise of a put option, and plans to cancel the bonds via Korea Securities Depository.
The acquisition was funded by internal capital, with the settlement date on June 1, 2026. This is the third redemption after prior extensions (1st: May 22, 2nd: May 29), completing a series of early redemptions.
After acquisition, the remaining face value of the convertible bonds is approximately KRW 17.48B (based on initial issuance). The conversion price, adjusted to KRW 25,592 as of Feb 23, 2026, is above the current stock price of KRW 21,850, leaving no conversion incentive.
The company faces high accrued interest costs (15% p.a.) and short-term redemption pressure, further depleting liquidity. Additional put option exercises on the remaining CB could sustain cash flow strain.
[AI Summary]This pre-maturity bond acquisition is an unavoidable redemption due to put option exercise. While the company used internal funds, repaying high-interest debt weighs on financial health. The remaining CB size (KRW 17.48B) remains substantial with no conversion incentive, and potential further redemptions could negatively impact share price and creditworthiness, warranting risk management.
KOSDAQ Filing Information
Filing: Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity After Issuance (1st Series)